Nader joined Frazier Healthcare Partners in 1991 and has served on the firm’s management committee and led its Growth Buyout strategy since 1995. Under his leadership, the team has successfully raised over $4 billion of limited partner capital for 10 investment vehicles and has generated over $4.2 billion in realizations.
During his 29-year tenure with the firm, he has been responsible for and served on the boards of successful investments in Aspen Education Group (served as Chairman and acquired by Bain Capital), CHG Healthcare (acquired by J.W. Childs Associates), Priority Solutions International (acquired by Thermo Fisher NASDAQ: TMO), Bravo Health (acquired by HealthSpring which was subsequently acquired by Cigna NYSE: CI), Laboratory Supply Company (acquired by McKesson NYSE: MCK), Pentec Health (Acquired by NEP), Solis Mammography (acquired by Madison Dearborn), and DSI Renal (merged with U.S. Renal Care and ultimately acquired by Bain Capital). He currently serves on the Boards of United Digestive, Northfield Medical, Alteon Health, MedData and Accuity Delivery Systems.
Prior to joining Frazier, he was an associate at Goldman Sachs in New York.
Mr. Naini received his M.B.A from the Leonard N. Stern School of Business at New York University and a B.A. in Molecular Biology from the University of Pennsylvania.
New York University Stern School of Business (M.B.A)
University of Pennsylvania (B.A)